RNXT – renovorx, inc. (US:NASDAQ)
Stock Stats
News
RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9th
RenovoRx (NASDAQ:RNXT) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
RenovoRx (NASDAQ:RNXT) had its price target raised by analysts at Ascendiant Capital Markets from $12.00 to $12.50. They now have a "buy" rating on the stock.
RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th
RenovoRx Inc (RNXT) Q3 2025 Earnings Report Preview: What To Expect [Yahoo! Finance]
Form 4 RenovoRx, Inc. For: Nov 21 Filed by: Agah Ramtin
Form 8-K RenovoRx, Inc. For: Nov 14
Form 424B5 RenovoRx, Inc.
Form S-3 RenovoRx, Inc.
Form SCHEDULE 13G/A RenovoRx, Inc. Filed by: AWM Investment Company, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.